1. Treatment of Sarcoidosis-Associated Pulmonary Hypertension.
- Author
-
Barnett, Christopher F., Bonura, Eric J., Nathan, Steven D., Ahmad, Shahzad, Shlobin, Oksana A., Osei, Kwabena, Zaiman, Ari L., Hassoun, Paul M., Moller, David R., Barnett, Scott D., and Girgis, Reda E.
- Subjects
- *
HYPERTENSION , *MEDICAL centers , *SARCOIDOSIS , *THERAPEUTICS - Abstract
The article presents the results of a study on the experience of two health care centers in New York in the management of patients with sarcoidosis-associated pulmonary arterial hypertension (PAH). According to the authors, 22 patients with sarcoidosis treated with PAH-specific therapies experienced an increase in their mean six-minute walk distance, a greater increment in exercise capacity, and reduce in mean pulmonary artery pressure. They add that the survival rates of one- and three-year transplant free patients ranged from 74 to 90 percent.
- Published
- 2009
- Full Text
- View/download PDF